Process of receiving CAR T-cell therapy?

CAR T-cell therapy functions by first extracting T-cells from the patient, genetically modifying them outside the body to express CARs that can recognize cancer-specific antigens. These engineered CAR T-cells are then expanded in the lab and infused back into the patient where they can selectively target and destroy cancer cells, utilizing the immune system to combat the disease. This approach aims to harness the body’s natural defenses against cancer, offering a personalized and potentially durable treatment option.

CAR T-cell therapy involves several key mechanisms:

1. Collection of T-cells: T-cells are obtained from the patient’s blood through leukapheresis, a process similar to blood donation.

2. Genetic Engineering: In the laboratory, the collected T-cells are modified to express CARs on their surface. These CARs are synthetic receptors that are designed to recognize specific antigens present on cancer cells.

3. Expansion: The genetically modified CAR T-cells are cultured and expanded in large numbers to create a sufficient dose for treatment.

4. Infusion: Once the CAR T-cells are ready, they are infused back into the patient’s bloodstream. They circulate throughout the body and target cancer cells that express the corresponding antigen recognized by the CAR.

5. Target Recognition and Killing: When a CAR T-cell encounters a cancer cell that displays the antigen it is programmed to recognize, the CAR binding triggers activation of the T-cell. This activation leads to the release of cytotoxic molecules and cytokines, which can directly kill the cancer cell and recruit other immune cells to attack nearby cancer cells.

6. Persistence and Memory: Some CAR T-cells can persist in the body for months to years after infusion, providing ongoing surveillance and potential long-term protection against cancer recurrence.

7. Management of Side Effects: CAR T-cell therapy can lead to significant side effects, including cytokine release syndrome (CRS) and neurologic toxicity, which require careful monitoring and management by healthcare providers.

Overall, CAR T-cell therapy represents a sophisticated approach to cancer treatment by leveraging the patient’s own immune cells to target and destroy cancer cells with precision and potentially long-lasting effects.

Share this article